See also this year's filing and all EDGAR filings for this company.
PDF Report 0001114220_2012_Keryx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001114220, Keryx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 40,004,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,208,000 |
| 2 | PropertyPlantAndEquipmentNet | 67,000 |
| 3 | remainder_Assets | 209,000 |
| 4 | LiabilitiesCurrent | 9,767,000 |
| 5 | LiabilitiesNoncurrent | 35,000 |
| 6 | remainder_Liabilities | 2,639,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,737,000 |
| 9 | ResearchAndDevelopmentExpense | 27,012,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 5,000,000 |
| 12 | remainder_NetIncome | 626,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,488,000 |
| 1 | Liabilities | 12,441,000 |
| 2 | Expenses | 33,749,000 |
| 3 | Revenues | 5,000,000 |
| 4 | StockholdersEquity | 31,047,000 |
| 5 | NetIncome | -28,123,000 |
| 6 | ComprehensiveNetIncome | -28,123,000 |
| 7 | BaseVar | 47,652,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.41 |
| 9 | EconomicCapitalRatio | 2.62 |
Edgar->Model Mapping
Feature Distribution
